Revealing Engagement Patterns Among Hepatic Encephalopathy Patients

Launched by POWER LIFE SCIENCES INC. · Dec 29, 2023

Keywords

ClinConnect Summary

This clinical trial, titled "Revealing Engagement Patterns Among Hepatic Encephalopathy Patients," is focused on understanding why patients choose to participate in clinical trials for hepatic encephalopathy, a serious liver condition that can affect brain function. The researchers want to learn about the reasons behind patients deciding to join, leave, or come back to these studies. By uncovering these factors, they hope to make future research more relevant and effective, which can ultimately lead to new and better treatments for this condition.

To be eligible for this trial, participants need to be at least 18 years old and must not have received any prior treatment for hepatic encephalopathy. They will need to provide written consent to join the study. Importantly, the trial is not yet recruiting participants, but once it begins, those who join can expect to share their experiences and insights, helping to shape the future of treatment for this challenging illness.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Signed Written Informed Consent
• • Aged ≥ 18 years old
• • No prior treatment for hepatic encephalopathy
• Exclusion Criteria:
• • Participant is actively receiving study therapy in another
• • Inability to provide written informed consent
• • Women of childbearing potential without a negative pregnancy test; or women who are lactating.